Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: A pilot study

Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: A pilot study

Background: Individuals with schizophrenia are at elevated genetic risks for comorbid cannabis use, and often experience exacerbations of cognitive and psychotic symptoms when exposed to cannabis. These findings have led a number of investigators to examine cannabinoid CB1 receptor (CB1R) alteration...

Full description

Bibliographic Details
Main Authors: Shinnyi Chou, Kenneth N. Fish, David A. Lewis, Robert A. Sweet
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Neurobiology of Disease
Subjects:
Cannabinoid receptor
CB1
Cell type
Postmortem
Prefrontal cortex
Schizophrenia
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996123002772

Similar Items

Similar Items